Effects of C-section Delivery on Infant Brain Development
NCT ID: NCT03277612
Last Updated: 2023-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
9 participants
OBSERVATIONAL
2017-09-22
2019-03-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
C-Section
Infants delivered by C-section
No interventions assigned to this group
Vaginal Delivery
Infants delivered by spontaneous vaginal delivery after C-section.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton pregnancy recruited at or before 36 weeks of gestation
* Second parity with planned repeated C-section delivery or with planned spontaneous vaginal delivery after C-section.
Exclusion Criteria
* Sexually transmitted diseases
* Medical complications developed during pregnancy
* Medical complications developed during labor and delivery
* Emergency c-section delivery
* Infants born preterm or post-term
* Infants needing mechanical ventilation, have congenital abnormalities, birth defects, intrauterine growth restriction, low Apgar score (\<7), or other medical issues developed at birth or before 2 weeks of age affecting the outcome of interest as determined by the PI.
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arkansas Children's Hospital Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiawei Ou, PhD
Role: PRINCIPAL_INVESTIGATOR
Arkansas Children's Nutrition Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arkansas Children's Nutrition Center
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
206515
Identifier Type: -
Identifier Source: org_study_id